Keyphrases
After Surgery
15%
Age Groups
6%
Androgen Deprivation Therapy
21%
ARAMIS
10%
Bladder Cancer
6%
Breast Cancer
10%
Cancer Mortality
10%
Cancer Treatment
6%
Cancer-related
8%
Cardiovascular Disease
5%
Castration-resistant Prostate Cancer
12%
Clinically Significant Prostate Cancer
7%
Comorbidity
8%
Confidence Interval
22%
Cumulative Incidence
5%
Curative Treatment
5%
Darolutamide
16%
Disease-specific Mortality
6%
Drug Use
6%
Economic Factors
6%
Elderly Patients
10%
Enzalutamide
6%
EPIC-26
13%
Erectile Dysfunction
5%
Europe
12%
European Randomized Study of Screening for Prostate Cancer
10%
Euthyroid
10%
Expanded Prostate Cancer Index Composite
11%
Finland
32%
Functional Outcome
10%
Geoeconomics
6%
Hazard Ratio
13%
Hernia Repair
5%
High Risk
5%
High-grade Prostate Cancer
14%
Hypothyroid
7%
Hypothyroidism
15%
International Survey
10%
Laparoscopic Radical Prostatectomy
15%
Levothyroxine
6%
Long Non-coding RNA (LncRNA)
10%
Lower Urinary Tract Symptoms
10%
Lymph Node Metastasis
8%
Lynch Syndrome
10%
Magnetic Resonance Imaging
13%
Metastasis
6%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
19%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
10%
Non-associated
6%
Non-muscle Invasive Bladder Cancer (NMIBC)
6%
Nonmetastatic Prostate Cancer
6%
Nordic Countries
6%
Odds Ratio
5%
Oncogenesis
5%
Oncological Outcomes
10%
Operative Treatment
6%
Overall Survival
13%
Persistent Symptoms
5%
Placebo
6%
Population-based Cohort Study
6%
Post-diagnostic Support
5%
Primary Prostate Cancer
6%
Prognostic Factors
12%
Prostate
17%
Prostate Cancer
79%
Prostate Cancer Patients
10%
Prostate Cancer Risk
29%
Prostate Cancer Screening
22%
Prostate Radiotherapy
12%
Prostate-specific Antigen
12%
Prostatectomy
10%
Quality of Life
9%
Radical Prostatectomy
12%
Random Forest Algorithm
6%
Randomized Controlled Trial
12%
Randomized Trial
11%
Recurrence Rate
6%
Reoperation
7%
Risk Factors
5%
Risk of Death
10%
Robot-assisted
10%
Robot-assisted Laparoscopic Radical Prostatectomy
6%
Screening Trials
5%
Sensitivity Analysis
5%
Single Center
6%
Spouses
6%
Statin Use
15%
Statins
9%
Surgical Outcomes
6%
Sweden
5%
Tampere
6%
Three-dimensional (3D)
15%
Tolerability
12%
Total Prostate-specific Antigen
6%
Treatment-related Adverse Events
6%
Tumor
5%
University Hospital
8%
Urinary Incontinence
7%
Visual Analog Scale
7%
Well-being
5%
Medicine and Dentistry
Abdominal Wall Hernia
5%
Acute Coronary Syndrome
5%
Androgen
6%
Androgen Receptor
7%
Arm
8%
Bile Duct Stone
5%
Biopsy Technique
7%
Bladder Cancer
5%
Brain Ischemia
5%
Breast Cancer
5%
Breast Density
5%
Cancer Cell
9%
Cancer Diagnosis
5%
Cancer Mortality
17%
Cancer Risk
5%
Cancer Screening
16%
Cancer Therapy
8%
Carcinogenesis
5%
Castration Resistant Prostate Cancer
5%
CD3 Antigen
5%
Circulating Tumor DNA
5%
Clear Cell Renal Cell Carcinoma
5%
Clinician
5%
Cohort Analysis
8%
Colorectal Carcinoma
6%
Common Bile Duct Stone
5%
Comorbidity
7%
Conservative Treatment
6%
Continence
12%
COVID-19
5%
Cross Sectional Study
5%
Cystectomy
5%
Cytotoxic T-Cell
5%
Diseases
9%
Elderly Patient
10%
Endoscopic Retrograde Cholangiopancreatography
5%
Endoscopic Sphincterotomy
5%
Enuresis
5%
Evolution
5%
Gene Expression
10%
Genome Analysis
5%
Goiter
5%
Hazard Ratio
6%
Hereditary Nonpolyposis Colorectal Cancer
10%
Hernia Surgery
5%
Hernioplasty
6%
Hypospadias
5%
Hypothyroidism
15%
Immunocompetent Cell
5%
Inguinal Hernia
5%
Kallikrein
5%
Krukenberg Tumor
5%
Levothyroxine
6%
Liotrix
10%
Long Untranslated RNA
5%
Lower Urinary Tract Symptom
5%
Lymph Node Metastasis
8%
Magnetic Resonance Imaging
16%
Maintenance Therapy
5%
Malignant Neoplasm
11%
Masculinity
5%
Meta-Analysis
5%
Metastatic Carcinoma
6%
microRNA
5%
Minimal Residual Disease
5%
Neoplasm
10%
Non Muscle Invasive Bladder Cancer
5%
Oncology
5%
Overall Survival
6%
Papillary Thyroid Cancer
5%
Personalized Medicine
5%
PI3K/AKT/mTOR Pathway
5%
Primary Hyperparathyroidism
5%
Prognostic Factor
11%
Prostate Cancer
100%
Prostate Specific Antigen
13%
Prostatectomy
34%
Quality of Life
7%
Randomized Controlled Trial
15%
Rectum Resection
5%
Recurrence Risk
5%
Recurrent Disease
8%
Reoperation
7%
Robot-Assisted Prostatectomy
12%
Social Interaction
5%
Surgery
6%
Systematic Review
5%
Thymidine Kinase 1
5%
Thyroid Antibody
5%
Thyroid Gland
21%
Thyroid Hormone
5%
Thyroid Nodule
5%
Tibial Plateau Fracture
5%
Urinary System
9%
Urine Incontinence
5%
Visual Analog Scale
7%